The extracellular domain of Her2 in serum as a biomarker of breast cancer. [electronic resource]
- Laboratory investigation; a journal of technical methods and pathology 06 2018
- 696-707 p. digital
Publication Type: Journal Article; Review
1530-0307
10.1038/s41374-018-0033-8 doi
Biomarkers, Tumor--blood Breast Neoplasms--blood Drug Resistance, Neoplasm Female Humans Neoplasm Metastasis Neoplasm Recurrence, Local Prognosis Protein Domains Receptor, ErbB-2--antagonists & inhibitors